Association of eNOS gene polymorphisms with renal disease in Caucasians with type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 91, Issue 3, 2011, Pages 353-362

  Santos, Kátia G ^a,b   Crispim, Daisy ^b   Canani, Luís H ^b   Ferrugem, Paula T ^a   Gross, Jorge L ^b   Roisenberg, Israel ^c  

^a UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Diabetic nephropathy; Endothelial nitric oxide synthase (eNOS); Polymorphism; Renal disease; Type 2 diabetes

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; ALBUMINURIA; ARTICLE; BAYES THEOREM; BRAZIL; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; LOGISTIC REGRESSION ANALYSIS; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT;

AGED; BRAZIL; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC;

EID: 79952363928     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.12.029     Document Type: Article

References (48)

1. Zelmanovitz T., Gerchman F., Balthazar A.P.S., Thomazelli F.C.S., Matos J.D., Canani L.H. Diabetic nephropathy. Diabetol Metab Syndr 2009, 1. 10.1186/1758.5996.1.10.
2. Freedman B.I., Bostrom M., Daeihagh P., Bowden D.W. Genetic factors in diabetic nephropathy. Clin J Am Soc Nephrol 2007, 2:1306-1316.
3. Placha G., Canani L.H., Warram J.H., Krolewski A.S. Evidence for different susceptibility genes for proteinuria and ESRD in type 2 diabetes. Adv Chronic Kidney Dis 2005, 12:155-169.
4. Imperatore G., Hanson R.L., Pettitt D.J., Kobes S., Bennett P.H., Knowler W.C., et al. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Diabetes 1998, 47:821-830.
5. Krolewski A.S., Poznik G.D., Placha G., Canani L., Dunn J., Walker W. A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes. Kidney Int 2006, 69:129-136.
6. Förstermann U. Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med 2008, 5:338-349.
7. Dudzinski D.M., Michel T. Life history of eNOS: partners and pathways. Cardiovasc Res 2007, 75:247-260.
8. Wattanapitayakul S.K., Mihm M.J., Young A.P., Bauer J.A. Therapeutic implications of human endothelial nitric oxide synthase gene polymorphism. Trends Pharmacol Sci 2001, 22:361-368.
9. Ahluwalia T.S., Ahuja M., Rai T.S., Kohli H.S., Sud K., Bhansali A., et al. Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians. Mol Cell Biochem 2008, 314:9-17.
10. Asakimori Y., Yorioka N., Yamamoto I., Okumoto S., Doi S., Hirai T., et al. Endothelial nitric oxide synthase intron 4 polymorphism influences the progression of renal disease. Nephron 2001, 89:219-223.
11. Asakimori Y., Yorioka N., Taniguchi Y., Ito T., Ogata S., Kyuden Y., et al. T(-786) →C polymorphism of the endothelial nitric oxide synthase gene influences the progression of renal disease. Nephron 2002, 91:747-751.
12. Bellini M.H., Figueira M.N., Piccoli M.F., Marumo J.T., Cendoroglo M.S., Neto M.C., et al. Association of endothelial nitric oxide synthase gene intron 4 polymorphism with end-stage renal disease. Nephrology 2007, 12:289-293.
13. Buraczynska M., Ksiazek P., Zaluska W., Nowicka T., Ksiazek A. Endothelial nitric oxide synthase gene intron 4 polymorphism in patients with end-stage renal disease. Nephrol Dial Transplant 2004, 19:2302-2306.
14. Ezzidi I., Mtiraoui N., Mohamed M.B.H., Mahjoub T., Kacem M., Almawi W.Y. Association of endothelial nitric oxide synthase Glu298Asp. 4b/a, and -786T>C gene variants with diabetic nephropathy. J Diabetes Complicat 2008, 22:331-338.
15. Liu Y., Burdon K.P., Langefeld C.D., Beck S.R., Wagenknecht L.E., Rich S.S., et al. T-786C polymorphism of the endothelial nitric oxide synthase gene is associated with albuminuria in the diabetes heart study. J Am Soc Nephrol 2005, 16:1085-1090.
16. Nagase S., Suzuki H., Wang Y., Kikuchi S., Hirayama A., Ueda A., et al. Association of ecNOS gene polymorphisms with end stage renal diseases. Mol Cell Biochem 2003, 244:113-118.
17. Neugebauer S., Baba T., Watanabe T. Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes 2000, 49:500-503.
18. Noiri E., Satoh H., Taguchi J., Brodsky S.V., Nakao A., Ogawa Y., et al. Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension 2002, 40:535-540.
19. Shin Shin Y., Baek S.H., Chang K.Y., Park C.W., Yang C.W., Jin D.C., et al. Relations between eNOS Glu298Asp polymorphism and progression of diabetic nephropathy. Diabetes Res Clin Pract 2004, 65:257-265.
20. Suzuki H., Nagase S., Kikuchi S., Wang W., Koyama A. Association of a missense Glu298Asp mutation of the endothelial nitric oxide synthase gene with end stage renal disease. Clin Chem 2000, 46:1858-1860.
21. Thaha M., Pranawa M., Yogiantoro, Sutjipto, Sunarjo M., Tanimoto, et al. Association of endothelial nitric oxide synthase Glu298Asp polymorphism with end-stage renal disease. Clin Nephrol 2008, 70:144-154.
22. Tiwari A.K., Prasad P., Thelma B.K., Kumar K.M., Ammini A.C., Gupta A.A., et al. Oxidative stress pathway genes and chronic renal insufficiency in Asian Indians with type 2 diabetes. J. Diabetes Complicat 2009, 23:102-111.
23. Cai H., Wang X., Colagiuri S., Wilcken D.E.L. A common Glu298→Asp (894G→T) mutation at exon 7 of the endothelial nitric oxide synthase gene and vascular complications in type 2 diabetes. Diabetes Care 1998, 21:2195-2196.
24. Degen B., Schmidt S., Ritz E. A polymorphism in the gene for the endothelial nitric oxide synthase and diabetic nephropathy. Nephrol Dial Transplant 2001, 16:185.
25. Freedman B.I., Yu H., Anderson P.J., Roh B.H., Rich S.S., Bowden D.W. Genetic analysis of nitric oxide and endothelin in end-stage renal disease. Nephrol Dial Transplant 2000, 15:1794-1800.
26. Fujita H., Narita T., Meguro H., Ishii T., Hanyu O., Suzuki K., et al. Lack of association between an ecNOS gene polymorphism and diabetic nephropathy in type 2 diabetic patients with proliferative diabetic retinopathy. Horm Metab Res 2000, 32:80-83.
27. Ksiazek P., Wojewoda P., Muc K., Buraczynska M. Endothelial nitric oxide synthase gene intron 4 polymorphism in type 2 diabetes mellitus. Mol Diagn 2003, 7:119-123.
28. Lamnissou K., Zirogiannis P., Trygonis S., Demetriou K., Pierides A., Koptides M. Evidence for association of endothelial cell nitric oxide synthase gene polymorphism with earlier progression to end-stage renal disease in a cohort of Hellens from Greece and Cyprus. Genet Test 2004, 8:319-324.
29. Lin S., Qu H., Qiu M. Allele A in intron 4 of ecNOS gene will not increase the risk of diabetic nephropathy in type 2 diabetes of Chinese population. Nephron 2002, 91:768.
30. Ohtoshi K., Yamasaki Y., Gorogawa S., Hayaishi-Okano R., Node K., Matsuhisa M., et al. Association of -786T-C mutation of endothelial nitric oxide synthase gene with insulin resistance. Diabetologia 2002, 45:1594-1601.
31. Shimizu T., Onuma T., Kawamori R., Makita Y., Tomino Y. Endothelial nitric oxide synthase gene and the development of diabetic nephropathy. Diabetes Res Clin Pract 2002, 58:179-185.
32. Tamemoto H., Ishikawa S., Kawakami M. Association of the Glu298Asp polymorphism of the eNOS gene with ischemic heart disease in Japanese diabetic subjects. Diabetes Res Clin Pract 2008, 80:275-279.
33. Taniwaki H., Ishimura E., Matsumoto N., Emoto M., Inaba M., Nishizawa Y. Relations between ACE gene and ecNOS gene polymorphisms and resistive index in type 2 diabetic patients with nephropathy. Diabetes Care 2001, 24:1653-1660.
34. Ukkola O., Erkkilä P.H., Savolainen M.J., Kesäniemi Y.A. Lack of association between polymorphisms of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus. J Intern Med 2001, 249:451-459.
35. Wang Y., Kikuchi S., Suzuki H., Nagase S., Koyama A. Endothelial nitric oxide synthase gene polymorphism in intron 4 affects the progression of renal failure in non-diabetic renal diseases. Nephrol Dial Transplant 1999, 14:2898-2902.
36. Zintzaras E., Papathanasiou A.A., Stefanidis I. Endothelial nitric oxide synthase gene polymorphisms and diabetic nephropathy: a HuGE review and meta-analysis. Genet Med 2009, 11:695-706.
37. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2005, 28:S37-S42.
38. Wilkinson C.P., Ferris F.L., Klein R.E., Lee P.P., Agardh C.D., Davis M., et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003, 110:1677-1682.
39. Lahiri D.K., Nurnberger J.I. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991, 19:5444.
40. Tanus-Santos J.E., Desai M., Flockhart D.A. Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 2001, 11:719-725.
41. Zintzaras E., Lau J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol 2008, 61:634-645.
42. Abramson J.H., Gahlinger P.M. Computer programs for epidemiologic analyses: PEPI. Version 4.0 2002, Sagebrush Press, Salt Lake City.
43. Hedrick P.W. Gametic disequilibrium measures: proceed with caution. Genetics 1987, 17:331-341.
44. Stephens M., Smith N.J., Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001, 68:978-989.
45. Stephens M., Scheet P. Accounting for decay of linkage disequilibrium in haplotype inference and missing data imputation. Am J Hum Genet 2005, 76:449-462.
46. Christensen P.K., Larsen S., Horn T., Olsen S., Parving H.H. Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy. Kidney Int 2000, 58:1719-1731.
47. Marroni A.S., Metzger I.F., Souza-Costa D.C., Nagassaki S., Sandrim V.C., Correa R.X., et al. Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms. Nitric Oxide 2005, 12:177-182.
48. de Syllos R.W.C., Sandrim V.C., Lisboa H.R.K., Tres G.S., Tanus-Santos J.E. Endothelial nitric oxide synthase genotype and haplotype are not associated with diabetic retinopathy in diabetes type 2 patients. Nitric Oxide 2006, 15:417-422.